News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

March 2015

Top

Ireland's Horizon Pharma to buy Hyperion for $1.1bn
31 March 2015 Irish biopharmaceutical firm Horizon Pharma has signed an agreement to acquire US-based Hyperion Therapeutics for around $1.1bn....

Israel’s Teva to buy US-based Auspex for $3.5bn
31 March 2015 Israel-based Teva Pharmaceutical Industries has signed an agreement to acquire US late-clinical stage biopharmaceutical firm Auspex Pharmaceuticals, for around $3.5bn in equity...

GSK to provide meningitis B vaccine in UK
30 March 2015 GlaxoSmithKline (GSK) has entered an agreement with the UK's Department of Health to provide meningitis B vaccine for babies in the country....

CHMP recommends new single-pill combination therapy to treat type 2 diabetes
30 March 2015 The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer Ingelheim (BI) and Eli Lilly and Company’s single-pill combination...

FDA grants orphan drug designation for Aduro’s immuno-oncology product candidate
27 March 2015 Aduro Biotech has received orphan drug designation from US Food and Drug Administration (FDA) for its immuno-oncology product candidate CRS-207 to treat...

GSK obtains Japanese approval for Encruse Ellipta to treat COPD
27 March 2015 GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta...

Sanofi Pasteur’s Quadracel approved to treat children between the ages of four and six
26 March 2015 Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated...

India’s Sun Pharma completes $3.2bn merger deal with Ranbaxy
26 March 2015 India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal....

AstraZeneca and HSCI partner to develop new medicines for diabetes
25 March 2015 AstraZeneca has established a five-year research collaboration with Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells. ...

Agios’s pyruvate kinase deficiency treatment receives FDA orphan drug designation
25 March 2015 Agios Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its investigational medicine AG-348 to treat pyruvate kinase (PK) deficiency, a...

Takeda and ImmunoGen partner to develop anti-cancer therapeutics
24 March 2015 Japanese drug maker Takeda Pharmaceutical Company, through its wholly owned subsidiary Millennium Pharmaceuticals, has signed an agreement with US-based ImmunoGen to develop and...

GSK and CSHL to develop new treatment for obesity and type 2 diabetes
24 March 2015 US-based Cold Spring Harbor Laboratory (CSHL) has collaborated with British drugmaker GlaxoSmithKline (GSK) to develop a treatment for obesity and type 2 diabetes....

Dilaforette’s sevuparin obtains FDA orphan drug designation to treat SCD
23 March 2015 Swedish firm Dilaforette has received orphan drug designation from the US Food and Drug Administration (FDA) for its sevuparin (DF02) to treat patients with sickle-cell disease (SCD). ...

China’s Innovent and Eli Lilly partner to develop three new cancer treatments
23 March 2015 US-based Eli Lilly and Company has partnered with Chinese drug development firm Innovent Biologics to develop and commercialise three cancer treatments over the next decade....

Eli Lilly and Hanmi to develop BTK inhibitor to treat autoimmune diseases
20 March 2015 US-based Eli Lilly and Company has signed an exclusive licence and collaboration agreement with Hanmi Pharmaceutical to develop and commercialise an immunological therapy....

Evotec signs five-year multi-component agreement with Sanofi
20 March 2015 Germany-based Evotec has signed an agreement with French drugmaker Sanofi for a major multi-component strategic partnership over the next five years....

PARP inhibitors effective against cancer cells with fault CBLC gene, says ICR
19 March 2015 Researchers at London's Institute of Cancer Research (ICR) have found that cancer cells with a fault in the protein-coding CBLC gene could be sensitive to the poly ADP-ribose polymerase...

Vertex’s Kalydeco obtains FDA approval to treat CF in children
19 March 2015 Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Kalydeco (ivacaftor) to treat cystic fibrosis (CF) in children aged between two and five years....

Lupin to acquire remaining 40% stake in Pharma Dynamics
18 March 2015 India-based Lupin has signed an agreement to acquire the remaining 40% interest in South African generics maker Pharma Dynamics (PD) on undisclosed terms....

Actavis acquires Botox-maker Allergan for $70.5bn
18 March 2015 Actavis has completed the acquisition of US-based Botox-maker Allergan, in a deal valued around...

Emergent produces modified vaccinia Ankara Ebola Zaire vaccine candidate
17 March 2015 US-based Emergent BioSolutions has produced a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ)....